AllCells® GMP Cryopreserved PBMCs
The high cost and risk of manufacturing failures in cell and gene therapy (CGT) pose significant challenges for timely production and delivery of safe, effective, and reliable allogeneic therapies to patients. Discovery’s AllCells® GMP Cryopreserved Peripheral Blood Mononuclear Cells (PBMCs) address these challenges by overcoming logistical and target cell isolation bottlenecks. Access to characterized, high-quality, GMP PBMCs minimizes manufacturing risks, enhances overall process efficiency, which results in cost-savings across development and commercialization.
With an agile team and advanced infrastructure, Discovery has supported many complex CGT programs. We specialize in developing tailored solutions that allow our clients to confidently translate and scale their CGT programs.
Why Choose AllCells® GMP Cryopreserved PBMCs?
- Discovery maintains full control over the entire donor process from donor screening and leukapheresis collection to cell processing and cryopreservation.
- Leukapheresis collections from donors are processed in an ISO 7 cleanroom and PBMCs are isolated in a closed system.
- Our integrated donor clinic and processing lab ensure minimal time between collection, processing, and cryopreservation, preserving cell quality and reducing logistical hurdles.
- Clients can pre-screen off-the-shelf PBMC lots to predict downstream cell performance without the need for a Statement of Work (SOW) or Master Service Agreement (MSA).
| Parameter | Off-the-Shelf | Made-to-Order |
|---|---|---|
| Donor meets 21 CRF 1271 criteria | ✓ | ✓ |
| Program-specific IDM and donor criteria | – | ✓ |
| Closed isolation system using the Sepax C-Pro | ✓ | ✓ |
| Viability and cell concentration specifications | ✓ | ✓ |
| Donor HLA typed | ✓ | ✓ |
| Vial format | ✓ | ✓ |
| Bag format | Inquire | ✓ |
| Lot pre-screening | ✓ | Inquire |
| SOW/MSA requirement | – | ✓ |
| Certificate of Analysis, Summary of Records, Immunophenotype Report | ✓ | ✓ |
Industry First Ready-to-Use GMP Cryopreserved PBMC Vials
- End-to-End Donor Control Builds Regulatory Confidence
We manage the full donor ecosystem—from screening through GMP processing—to ensure traceability, consistency, and compliance. - High-Quality Cells, Delivered Faster
Rapid isolation with minimal downtime preserves viability and function, providing more reliable starting material than competitors who wait days to process. - Exclusive Off-the-Shelf, Predictive Batches
The only provider with ready-to-use GMP PBMC inventory that can be pre-screened to predict performance and maximize manufacturing success. - Faster Timelines with Lower Operational Burden
Off-the-shelf availability eliminates contracting and scheduling delays, helping CGT programs advance faster while easing operational workload.
Limited Time Offer: Get the First 2 Vials 50% Off
This promotion will expire on December 31, 2025.